Dr Greenberg reports his thoughts on the Sureglide device and preventing lacerations during cesarean, Überlube and helping women with vaginal dryness and dyspareunia, and TruClear ULTRA Mini tissue removal device for mechanical morcellation.
Uterine Fibroid and Tissue Removal
Can adopting quality measures decrease the cesarean rate? Plus: The Government Accountability Office issues a report on power morcellators and the FDA's system of evaluation. Also, does the volume of one type of heart fat indicate the risk of heart disease?
Fibroids are extremely common in women of reproductive age. One large study reported that 70% of Caucasian and 80% of African-American women had at least one ultrasound- or pathology-confirmed fibroid by the end of their reproductive years. While many of these women experience no negative effects of fibroids on their reproductive function, a significant number are at increased risk of infertility, miscarriage, or poor obstetric outcomes.
A small feasibility study of a new containment bag for power morcellation shows that it may be reliable for even a large specimen. The findings, about the Espiner EcoSac 230, were presented at the 45th AAGL Global Congress in Orlando, Florida.
Olympus America Inc announces that the company has received 510(k) clearance from the US Food and Drug Administration (FDA) for the company’s next-generation laparoscopic PK Morcellator, a system for laparoscopic tissue containment and extraction.
A study looks at whether myomectomies were also impacted by the FDA safety communication. Also, chronically ill mothers may be more likely to give birth to children with heart disease. Plus: Can antenatal steroids reduce mortality in extreme prematurity?